Fcrn Antagonists And Methods Of Use

Patent No. EP3087095 (titled "Fcrn Antagonists And Methods Of Use") was filed by Argen X on Dec 23, 2014. The application was issued on Aug 7, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
SANOFI	May 7, 2020	MATHYS & SQUIRE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Sep 21, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Sep 21, 2021
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Sep 16, 2021
Termination of the opposition proceedings with maintenance of patent
Jul 1, 2021
(Electronic) Receipt
Jul 1, 2021
Advice of delivery
Jun 7, 2021
Decision to discontinue the opposition proceedings
Jun 7, 2021
Transmittal of decision / summons - opposition
Feb 22, 2021
(Electronic) Receipt
Feb 22, 2021
Auxiliary request during Opposition procedure - 01
Feb 22, 2021
Auxiliary request during Opposition procedure - 02
Feb 22, 2021
Auxiliary request during Opposition procedure - 03
Feb 22, 2021
Reply to an examination report in opposition proceedings
Feb 22, 2021
Request for interpreters during oral proceedings
Dec 22, 2020
Annex to the communication - opposition
Dec 22, 2020
Brief communication - Opposition proceedings
Dec 22, 2020
Communication inviting the parties to file observations
Dec 22, 2020
Internal form - Opposition/addressees
Dec 8, 2020
Brief communication - Opposition proceedings
Dec 8, 2020
Brief communication - Opposition proceedings
Dec 2, 2020
(Electronic) Receipt
Dec 2, 2020
Letter accompanying subsequently filed items
Dec 2, 2020
Withdrawal of an opposition
Nov 3, 2020
Brief communication - Opposition proceedings
Oct 28, 2020
(Electronic) Receipt
Oct 28, 2020
Auxiliary request during Opposition procedure
Oct 28, 2020
Auxiliary request during Opposition procedure
Oct 28, 2020
Auxiliary request during Opposition procedure - 01
Oct 28, 2020
Auxiliary request during Opposition procedure - 02
Oct 28, 2020
Citation in opposition procedure - 040
Oct 28, 2020
Citation in opposition procedure - 041
Oct 28, 2020
Citation in opposition procedure - 042
Oct 28, 2020
Citation in opposition procedure - 043
Oct 28, 2020
Consolidated list of cited opposition documents
Oct 28, 2020
Main request during Opposition procedure
Oct 28, 2020
Main request during Opposition procedure
Oct 28, 2020
Reply of the patent proprietor to the notice(s) of opposition
Oct 28, 2020
Reply of the patent proprietor to the notice(s) of opposition
Oct 28, 2020
Request for interpreters during oral proceedings
Jun 18, 2020
Communication of a notice of opposition and request to file observations
Jun 18, 2020
Notice of further oppositions to opponent(s)
May 25, 2020
Communication of a notice of opposition - first information to patent proprietor
May 7, 2020
(Electronic) Receipt
May 7, 2020
Citation in opposition procedure - 001
May 7, 2020
Citation in opposition procedure - 002
May 7, 2020
Citation in opposition procedure - 002
May 7, 2020
Citation in opposition procedure - 003
May 7, 2020
Citation in opposition procedure - 004
May 7, 2020
Citation in opposition procedure - 005
May 7, 2020
Citation in opposition procedure - 006
May 7, 2020
Citation in opposition procedure - 007
May 7, 2020
Citation in opposition procedure - 008
May 7, 2020
Citation in opposition procedure - 009
May 7, 2020
Citation in opposition procedure - 010
May 7, 2020
Citation in opposition procedure - 011
May 7, 2020
Citation in opposition procedure - 012
May 7, 2020
Citation in opposition procedure - 013
May 7, 2020
Citation in opposition procedure - 014
May 7, 2020
Citation in opposition procedure - 015
May 7, 2020
Citation in opposition procedure - 016
May 7, 2020
Citation in opposition procedure - 017
May 7, 2020
Citation in opposition procedure - 018
May 7, 2020
Citation in opposition procedure - 019
May 7, 2020
Citation in opposition procedure - 020
May 7, 2020
Citation in opposition procedure - 021
May 7, 2020
Citation in opposition procedure - 022
May 7, 2020
Citation in opposition procedure - 023
May 7, 2020
Citation in opposition procedure - 024
May 7, 2020
Citation in opposition procedure - 025
May 7, 2020
Citation in opposition procedure - 026
May 7, 2020
Citation in opposition procedure - 027
May 7, 2020
Citation in opposition procedure - 028
May 7, 2020
Citation in opposition procedure - 029
May 7, 2020
Citation in opposition procedure - 030
May 7, 2020
Citation in opposition procedure - 031
May 7, 2020
Citation in opposition procedure - 032
May 7, 2020
Citation in opposition procedure - 033
May 7, 2020
Citation in opposition procedure - 034
May 7, 2020
Citation in opposition procedure - 035
May 7, 2020
Citation in opposition procedure - 036
May 7, 2020
Citation in opposition procedure - 037
May 7, 2020
Citation in opposition procedure - 038
May 7, 2020
Citation in opposition procedure - 039
May 7, 2020
International publication (Pamphlet)
May 7, 2020
International publication (Pamphlet)
May 7, 2020
Notice of opposition
May 7, 2020
Notice of opposition
May 7, 2020
Notice of opposition
Oct 21, 2019
Submission concerning representation
Aug 19, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 11, 2019
Decision to grant a European patent
Jul 1, 2019
Communication of the registration of a transfer or change of name and/or address
Jun 21, 2019
(Electronic) Receipt
Jun 21, 2019
Filing of the translations of the claims
Jun 21, 2019
French translation of claims
Jun 21, 2019
German translation of the claims
Jun 21, 2019
Letter accompanying subsequently filed items
Mar 11, 2019
Submission concerning representation
Feb 22, 2019
Bibliographic data of the European patent application
Feb 22, 2019
Communication about intention to grant a European patent
Feb 22, 2019
Intention to grant (signatures)
Feb 22, 2019
Text intended for grant (clean copy)
Feb 22, 2019
Text intended for grant (version for approval)
Jan 31, 2019
(Electronic) Receipt
Jan 31, 2019
Amended claims with annotations
Jan 31, 2019
Claims
Jan 31, 2019
Letter accompanying subsequently filed items
Jan 31, 2019
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Oct 5, 2018
Bibliographic data of the European patent application
Oct 5, 2018
Communication about intention to grant a European patent
Oct 5, 2018
Intention to grant (signatures)
Oct 5, 2018
Text intended for grant (clean copy)
Oct 5, 2018
Text intended for grant (version for approval)
Jul 3, 2018
Submission concerning representation
Jun 6, 2018
(Electronic) Receipt
Jun 6, 2018
Amended claims with annotations
Jun 6, 2018
Amended description with annotations
Jun 6, 2018
Claims
Jun 6, 2018
Description
Jun 6, 2018
Letter accompanying subsequently filed items
Jun 6, 2018
Reply to communication from the Examining Division
Jan 31, 2018
Annex to the communication
Jan 31, 2018
Communication from the Examining Division
Oct 17, 2017
(Electronic) Receipt
Oct 17, 2017
Amended claims with annotations
Oct 17, 2017
Claims
Oct 17, 2017
Letter accompanying subsequently filed items
Oct 17, 2017
Reply to communication from the Examining Division
Aug 28, 2017
Communication of the registration of a transfer or change of name and/or address
Aug 9, 2017
Annexes in respect of a client data request
Aug 9, 2017
Annexes in respect of a client data request
Aug 9, 2017
Annexes in respect of a client data request
Jul 7, 2017
Annexes in respect of a client data request
Jul 7, 2017
Annexes in respect of a client data request
Jul 7, 2017
Annexes in respect of a client data request
Jul 7, 2017
Letter accompanying subsequently filed items
Jul 7, 2017
Submission concerning a transfer of rights (applicant)
Jun 27, 2017
Annex to the communication
Jun 27, 2017
Communication from the Examining Division
Jun 19, 2017
Examination started
Feb 13, 2017
(Electronic) Receipt
Feb 13, 2017
Amended claims filed after receipt of (European) search report
Feb 13, 2017
Amended claims with annotations
Feb 13, 2017
Amendments received before examination
Feb 13, 2017
Letter accompanying subsequently filed items
Oct 6, 2016
Notification on forthcoming publication of bibliographic data
Aug 4, 2016
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Aug 2, 2016
Communication to designated inventor
Aug 2, 2016
Communication to designated inventor
Aug 2, 2016
Communication to designated inventor
Aug 2, 2016
Communication to designated inventor
Aug 2, 2016
Communication to designated inventor
Aug 2, 2016
Communication to designated inventor
Jul 21, 2016
(Electronic) Receipt
Jul 21, 2016
Converted Sequence Listing
Jul 21, 2016
Request for entry into the European phase
Jul 12, 2016
Copy of the international preliminary report on patentability
May 9, 2016
Information on entry into European phase
Jul 23, 2015
Priority document (electronically transmitted)
Jul 2, 2015
Copy of the international search report
Jul 2, 2015
Published international application - A1
May 11, 2015
Written opinion of the ISA, boxes No. I to VIII
May 11, 2015
Written opinion of the ISA, cover sheet
May 11, 2015
Written opinion of the ISA, supplemental box
Mar 17, 2015
Notification of the recording of a change
Mar 17, 2015
Notification of the recording of a change
Feb 26, 2015
Annex
Feb 23, 2015
Notification of the recording of a change
Jan 16, 2015
Abstract
Jan 16, 2015
Annex
Jan 16, 2015
Claims
Jan 16, 2015
Description
Jan 16, 2015
Drawings

EP3087095

ARGEN X

Application Number: EP14827372A
Filing Date: Dec 23, 2014
Status: Granted And Under Opposition; Jul 5, 2019
Publication Date: Aug 7, 2019
External Links: Slate, Register , Google Patents

IP Verse

Fcrn Antagonists And Methods Of Use

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3087095